Global Biologics Outsourcing Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Biologics Outsourcing Market Research Report 2024
Outsourcing is increasing as a percentage of the whole manufacturing capacity due to relatively more of new product manufacturing is outsourced and facilities with products that become generic are non-core and are being divested.
According to MRAResearch’s new survey, global Biologics Outsourcing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Biologics Outsourcing market research.
Key companies engaged in the Biologics Outsourcing industry include Boehringer Ingelheim, Catalent, GenScript, Innovent Biologics, Syngene, Shanghai Medicilon, GL Biochem Corporation, GVK Biosciences Private and Horizon Discovery Group, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Biologics Outsourcing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Biologics Outsourcing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Biologics Outsourcing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Boehringer Ingelheim
Catalent
GenScript
Innovent Biologics
Syngene
Shanghai Medicilon
GL Biochem Corporation
GVK Biosciences Private
Horizon Discovery Group
Selexis
Lonza
Abzena
Adimab
Segment by Type
Antibody
Recombinant
Protein
Vaccines
Others
Vaccine & Therapeutics Development
Blood & Blood Related Products Testing
Cellular and Gene Therapy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Biologics Outsourcing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Biologics Outsourcing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Biologics Outsourcing market research.
Key companies engaged in the Biologics Outsourcing industry include Boehringer Ingelheim, Catalent, GenScript, Innovent Biologics, Syngene, Shanghai Medicilon, GL Biochem Corporation, GVK Biosciences Private and Horizon Discovery Group, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Biologics Outsourcing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Biologics Outsourcing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Biologics Outsourcing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Boehringer Ingelheim
Catalent
GenScript
Innovent Biologics
Syngene
Shanghai Medicilon
GL Biochem Corporation
GVK Biosciences Private
Horizon Discovery Group
Selexis
Lonza
Abzena
Adimab
Segment by Type
Antibody
Recombinant
Protein
Vaccines
Others
Segment by Application
Vaccine & Therapeutics Development
Blood & Blood Related Products Testing
Cellular and Gene Therapy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Biologics Outsourcing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source